UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Scissortail Wealth Management LLC

Key Points

• Scissortail Wealth Management LLC increased its holdings in UnitedHealth Group by 49.1% during the 1st quarter, owning a total of 4,829 shares valued at approximately $2.53 million.
• UnitedHealth Group reported EPS of $4.08 for the last quarter, missing the consensus estimate of $4.45, despite a 12.9% year-over-year increase in revenue.
• The company recently raised its quarterly dividend to $2.21 per share, reflecting a positive change from the previous $2.10, with an annualized dividend yield of 3.5%.

Scissortail Wealth Management LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 49.1% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,829 shares of the healthcare conglomerate's stock after purchasing an additional 1,590 shares during the quarter. Scissortail Wealth Management LLC's holdings in UnitedHealth Group were worth $2,529,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $26,000. Bayforest Capital Ltd increased its stake in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Kapitalo Investimentos Ltda acquired a new position in UnitedHealth Group in the fourth quarter valued at $41,000. Copia Wealth Management acquired a new position in UnitedHealth Group in the fourth quarter valued at $42,000. Finally, IAG Wealth Partners LLC acquired a new position in UnitedHealth Group in the first quarter valued at $42,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $6.07 during trading hours on Friday, reaching $250.74. 10,146,688 shares of the stock were exchanged, compared to its average volume of 18,423,422. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a 50 day simple moving average of $291.78 and a 200-day simple moving average of $405.18. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The stock has a market capitalization of $227.46 billion, a P/E ratio of 10.86, a P/E/G ratio of 1.62 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.80 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 3.5%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 38.30%.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director owned 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 over the last quarter. Insiders own 0.28% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on UNH. JPMorgan Chase & Co. lowered their price target on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research report on Wednesday. TD Securities reissued a "hold" rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Barclays reaffirmed an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, HSBC reaffirmed a "reduce" rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has an average rating of "Hold" and a consensus target price of $366.52.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.